UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 139

Sortiert nach

Chronic GVHD: review advances in prevention, novel endpoints, and targeted strategies

Hematology, 2023-12, Vol.2023 (1), p.164

2023

Link zum Volltext

Verfügbarkeit prüfen

Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis

The New England journal of medicine, 2023-06, Vol.388 (25), p.2338-2348, Article 2338

2023

Link zum Volltext

Verfügbarkeit prüfen

Venetoclax and hypomethylating agents in FLT3‐mutated acute myeloid leukemia

American journal of hematology, 2020-10, Vol.95 (10), p.1193-1199

2020

Link zum Volltext

Verfügbarkeit prüfen

Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot study

Leukemia & lymphoma, 2024-04, p.1-9

2024

Link zum Volltext

Verfügbarkeit prüfen

Strongyloides hyperinfection syndrome following haematopoietic stem cell transplantation

British journal of haematology, 2016-02, Vol.172 (4), p.496-496

2016

Link zum Volltext

Verfügbarkeit prüfen

Bone Marrow Harvest: A White Paper of Best Practices by the NMDP Marrow Alliance

Transplantation and cellular therapy, 2024-04, Vol.30 (7), p.663-680

2024

Link zum Volltext

Verfügbarkeit prüfen

P699: MAGROLIMAB ALTERS THE TUMOR MICROENVIRONMENT TO IMPROVE BONE MARROW FUNCTIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) AND HIGHER‐RISK MYELODYSPLASTIC SYNDROMES (HR‐MDS)

HemaSphere, 2023-08, Vol.7 (S3), p.e45153c5-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Donor Types and Outcomes of Transplantation in Myelofibrosis: A CIBMTR Study

Blood advances, 2024-06

2024

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of second allogeneic hematopoietic stem cell Transplantation (Allo-SCT) in patients with acute lymphoblastic leukemia (ALL)

Clinical lymphoma, myeloma and leukemia, 2015-06, Vol.15, p.S175-S175

2015

Link zum Volltext

Verfügbarkeit prüfen

Initial Characterization of Nexi-001, a Donor-Derived T-Cell Product, for the Treatment AML Patients That Have Relapsed after Allogeneic Hematopoietic Stem Cell Transplant

Blood, 2022-11, Vol.140 (Supplement 1), p.4521-4521

2022

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Hypomethylating Agents and BCL-2 Inhibitor on HLA Expression on THP-1 Cells

Blood, 2021-11, Vol.138 (Supplement 1), p.3990-3990

2021

Link zum Volltext

Verfügbarkeit prüfen

Learning what matters in allogeneic transplant: Insights into older patient preferences in an age-friendly multidisciplinary clinic

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e24029-e24029

2023

Link zum Volltext

Verfügbarkeit prüfen

An analysis of a first-in-human study of NEXI-001 donor-derived antigen-specific CD8+ T-cell treatment of relapsed AML after allogeneic hematopoietic cell transplantation (HCT)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.7043-7043

2023

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary Engraftment Syndrome: A Unique Complication of Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis

Blood, 2022-11, Vol.140 (Supplement 1), p.4726-4727

2022

Link zum Volltext

Verfügbarkeit prüfen

Red blood cell and platelet transfusion support in the first 30 and 100days after allogeneic hematopoietic cell transplant

Transfusion (Philadelphia, Pa.), 2020-10, Vol.60 (10), p.2225-2242

2020

Link zum Volltext

Verfügbarkeit prüfen

Multi-Antigen Primed T Cells Promote Apoptosis of Acute Myeloid Leukemia (AML)

Blood, 2021-11, Vol.138 (Supplement 1), p.4794-4794

2021

Link zum Volltext

Verfügbarkeit prüfen

Prediction of Graft-Versus-Host Disease in Recipients of Single Mismatched Unrelated Hematopoietic Cell Transplantation Donor Using a Highly Multiplexed Proteomic Assay, MHC-Pepseq

Blood, 2021-11, Vol.138 (Supplement 1), p.1808-1808

2021

Link zum Volltext

Verfügbarkeit prüfen

RBC and platelet transfusion support in the first 30 and 100days after haploidentical hematopoietic stem cell transplantation

Transfusion (Philadelphia, Pa.), 2019-11, Vol.59 (11), p.3371-3385

2019

Link zum Volltext

Verfügbarkeit prüfen

Access: A Multi-Center, Phase II Trial of HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Patients with Hematologic Malignancies

Blood, 2022-11, Vol.140 (Supplement 1), p.7591-7593

2022

Link zum Volltext

Verfügbarkeit prüfen

Novel Tissue-Specific Targeted Radiation Delivery Reduces GI Injury and T Cell Trafficking Attenuating Allogeneic Immune Attack to Reduce GvHD in a Murine BMT Model

Blood, 2022-11, Vol.140 (Supplement 1), p.4467-4469

2022

Link zum Volltext

Verfügbarkeit prüfen

Trial in Progress: A Phase 1 Umbrella Study of TCR-Engineered T Cells That Target HA-1 (TSC-100) and HA-2 (TSC-101) to Treat Residual Leukemia after Hematopoietic Cell Transplantation

Blood, 2022-11, Vol.140 (Supplement 1), p.7468-7469

2022

Link zum Volltext

Verfügbarkeit prüfen

A Phase 1 Study of WU-NK-101 in Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)

Blood, 2022-11, Vol.140 (Supplement 1), p.12740-12741

2022

Link zum Volltext

Verfügbarkeit prüfen

Durable Leukemia and HIV Remission without Antiviral Therapy Following an Allogeneic Hematopoietic Stem Cell Transplantation (alloHCT) Using a Donor with CCR5-Δ32/Δ32 Homozygosity for an Acute Myeloid Leukemia (AML) Patient

Blood, 2022-11, Vol.140 (Supplement 1), p.7597-7598

2022

Link zum Volltext

Verfügbarkeit prüfen

Promising Safety and Efficacy Results from an Ongoing Phase 1b Study of Pembrolizumab Combined with Decitabine in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Blood, 2022-11, Vol.140 (Supplement 1), p.6235-6236

2022

Link zum Volltext

Verfügbarkeit prüfen

Preliminary Results of the First-in-Human Study of Nexi-001, a Multi-Antigen Specific CD8+ T Cell Product, in Acute Myeloid Leukemia (AML) Patients with Relapsed Disease after Allogeneic Hematopoietic Cell Transplantation (Allo-HSCT) Demonstrate Early Signs of Safety, Tolerability and Robust Immune Responses

Blood, 2020-11, Vol.136 (Supplement 1), p.31-33

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 139

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieHla

ThemaAntithymocyte Globulin

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(138)

Publikationsform

Sprache

Englisch
(139)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Chronic GVHD: review advances in prevention, novel endpoints, and targeted strategies

Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis

Venetoclax and hypomethylating agents in FLT3‐mutated acute myeloid leukemia

Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot study

Strongyloides hyperinfection syndrome following haematopoietic stem cell transplantation

Bone Marrow Harvest: A White Paper of Best Practices by the NMDP Marrow Alliance

P699: MAGROLIMAB ALTERS THE TUMOR MICROENVIRONMENT TO IMPROVE BONE MARROW FUNCTIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) AND HIGHER‐RISK MYELODYSPLASTIC SYNDROMES (HR‐MDS)

Donor Types and Outcomes of Transplantation in Myelofibrosis: A CIBMTR Study

Outcomes of second allogeneic hematopoietic stem cell Transplantation (Allo-SCT) in patients with acute lymphoblastic leukemia (ALL)

Initial Characterization of Nexi-001, a Donor-Derived T-Cell Product, for the Treatment AML Patients That Have Relapsed after Allogeneic Hematopoietic Stem Cell Transplant

The Impact of Hypomethylating Agents and BCL-2 Inhibitor on HLA Expression on THP-1 Cells

Learning what matters in allogeneic transplant: Insights into older patient preferences in an age-friendly multidisciplinary clinic

An analysis of a first-in-human study of NEXI-001 donor-derived antigen-specific CD8+ T-cell treatment of relapsed AML after allogeneic hematopoietic cell transplantation (HCT)

Pulmonary Engraftment Syndrome: A Unique Complication of Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis

Red blood cell and platelet transfusion support in the first 30 and 100days after allogeneic hematopoietic cell transplant

Multi-Antigen Primed T Cells Promote Apoptosis of Acute Myeloid Leukemia (AML)

Prediction of Graft-Versus-Host Disease in Recipients of Single Mismatched Unrelated Hematopoietic Cell Transplantation Donor Using a Highly Multiplexed Proteomic Assay, MHC-Pepseq

RBC and platelet transfusion support in the first 30 and 100days after haploidentical hematopoietic stem cell transplantation

Access: A Multi-Center, Phase II Trial of HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide for Patients with Hematologic Malignancies

Novel Tissue-Specific Targeted Radiation Delivery Reduces GI Injury and T Cell Trafficking Attenuating Allogeneic Immune Attack to Reduce GvHD in a Murine BMT Model

Trial in Progress: A Phase 1 Umbrella Study of TCR-Engineered T Cells That Target HA-1 (TSC-100) and HA-2 (TSC-101) to Treat Residual Leukemia after Hematopoietic Cell Transplantation

A Phase 1 Study of WU-NK-101 in Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)

Durable Leukemia and HIV Remission without Antiviral Therapy Following an Allogeneic Hematopoietic Stem Cell Transplantation (alloHCT) Using a Donor with CCR5-Δ32/Δ32 Homozygosity for an Acute Myeloid Leukemia (AML) Patient

Promising Safety and Efficacy Results from an Ongoing Phase 1b Study of Pembrolizumab Combined with Decitabine in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Aktive Filter

Suchergebnisse filtern